 |
Merck's new lung drug wins FDA approvalMerck & Co's new two-in-one respiratory drug Dulera has been approved by the US Food and Drug Administration, the US company said on Thursday, confirming an earlier Reuters report. The inhaled treatment has been cleared for treatin More… |
Thursday 25 April 2024
